Camlin Fine's top R&D scientist resigns citing personal commitments
Anvarhusen Bilakhiya, VP – Principal Scientist and designated senior management, quits after a three-month notice. No strategic disruption is expected.
— 3 earlier stories on Camlin Fine Sciences Ltd. →What's new
- Resignation of VP – Principal Scientist (R&D) Anvarhusen Bilakhiya.
- Effective July 7, 2026, after serving three-month notice tendered on April 8.
- No indication of strategic disruption; role is non-C-suite.
Why this matters
While the loss of a senior R&D leader could slow innovation, the orderly transition and non-C-suite nature limit the immediate impact. For a mid-cap chemicals company with a market cap of ₹2,619 cr, this is a moderate management change.
What we're watching
- Whether a replacement is named in the coming months.
- Any commentary on R&D pipeline continuity in the next earnings call.
- If further senior departures follow.
The full read
Camlin Fine Sciences’ R&D chief is leaving, but the move looks orderly, not alarming. Anvarhusen Bilakhiya, Vice President – Principal Scientist (R&D) and designated senior management, resigned on April 8 and served a full three-month notice period, making his exit effective July 7. The company cited personal commitments. The analyst note flags this as a moderate event — the role is not C-suite, and there is no indication of broader strategic disruption. For a chemical company with a ₹2,619 cr market cap and a high-trailing P/E of 94.8, R&D leadership matters, but the recent story has been about vanillin pricing and core profitability, not a single scientist. The departure removes a key figure, but the three-month runway suggests a smooth handover. The open question is whether Camlin names a replacement quickly and maintains its innovation pipeline without missing a beat.
Questions answered
- Who is Anvarhusen Bilakhiya?
- He was Vice President – Principal Scientist (R&D) and a designated Senior Management Personnel at Camlin Fine Sciences.
- Why did he resign?
- He cited personal commitments as the reason for his resignation.
- When did he resign and when is it effective?
- He submitted his resignation on April 8, 2026, and served a three-month notice period, making it effective July 7, 2026.
- Is this resignation a sign of trouble?
- There is no indication of strategic disruption. The role is not C-suite (CEO/CFO/CTO) and the company had months to prepare for a transition.
- How important is this role to Camlin Fine?
- As head of R&D, the role is important for innovation, but the analyst note suggests moderate importance overall. The company has a market cap of about ₹2,619 cr and trailing sales of ₹425 cr in the latest quarter.
Camlin Fine Sciences Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on CAMLINFINE →- 7 Jul 2026 · 10:50 PM IST Camlin Fine's top R&D scientist resigns citing personal commitments
- 45d ago Camlin Fine Sciences cuts vanillin price guidance as costs surge
- 45d ago Camlin profit on Italian sale masks a still-lossmaking core
- 45d ago Camlin Fine Sciences cuts standalone losses, but revenue also shrank